Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2017

Feb 14, 2017

34519_dirs_2017-02-14_6acb983b-a293-43e5-b376-1aa003500a41.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-02-10

Reporting Person: Williams Elizabeth Luttrell (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-10 Incentive Stock Options $5.8400 A 10000.0000 Acquired 2027-02-09 Common Stock (10000.0000) Direct